Skip to main content
. 2006 Jun;80(12):5697–5707. doi: 10.1128/JVI.02729-05

TABLE 3.

Body weight changes and lung infection parameters during infection with WT and mutant virusesf

Virusa Mean % body wt change (g)b Lung virus titer (day 2 p.i.) (% of WT PFU) Lung parameters (day 6)
Consolidation scorec Histopathologyd
Lung wt (g) Lesions Hemorrhage
WT
    CCHH −15.8 (5.3 ± 0.9) × 108 (100)e 2.4 ± 0.2 226 ± 28 +/++ +/++
Double mutants
    ACAH +0.8 (9.6 ± 0.7) × 106* (1.8) 0.5 ± 0.4** 143 ± 30** +/++
    AAHH −2.5 (4.1 ± 0.3) × 107* (7.7) 0.9 ± 0.3** 185 ± 31 +/+++ −/+
Triple mutants
    CAAA −19.0 (4.9 ± 0.5) × 107* (9.2) 2.1 ± 0.3 195 ± 6 +/++ −/+
    ACAA −15.6 (1.1 ± 0.8) × 107* (2.1) 1.8 ± 0.8 210 ± 52 + −/+
    AAHA −3.6 (7.3 ± 0.7) × 107* (13.8) 1.9 ± 0.8 203 ± 26 ++ −/+
    AAAH +11.3 (1.1 ± 0.1) × 102** (<0.001) 0.0 ± 0.0** 120 ± 21** +
Quadruple mutant
    AAAA +11.9 (6.8 ± 0.1) × 101** (<0.001) 0.0 ± 0.0** 123 ± 13** +
a

The infecting virus dose was 105 PFU/mouse.

b

Between day 0 and day 6 of infection (groups of five mice).

c

Consolidation score is based upon the overall appearance of lungs on day 6. A higher score (range, 0 to 4) indicates more consolidation.

d

Severity scores: −, no lesions or hemorrhage; +, mild; ++, moderate; +++, severe. The results represent the average from groups of five mice.

e

Percentage of WT (CCHH virus) PFU.

f

*P < 0.05; **P < 0.01 compared to WT (CCHH virus).